Avant Brands Inc. announced the signing of an International Trademark Licensing Agreement granting IMC's German subsidiary, Adjupharm GmbH (?Adjupharm?), the exclusive right to launch Avant's brand, BLK MKT brand in the German cannabis market. The Licensing Agreement constitutes a significant expansion of the relationship between the two cannabis companies. In accordance with the terms outlined in the Trademark License Agreement, Avant has granted Adjupharm the license to utilize its BLK MKT cannabis brand for their cannabis products.

These products will exclusively feature cannabis cultivated by Avant in Canada and exported to Germany. The collaboration between the two companies anticipates a positive outcome in the emerging German medical cannabis market, especially following the recent legalization by the government on April 1st, 2024. This strategic partnership, timed with evolving German legislative changes, underscores a growing acknowledgment of cannabis' therapeutic advantages and signifies a progressive shift in drug policy within Germany.

Avant and IMC are confident the integration of Avant's BLK MKT premium cannabis flower, alongside IMC's adept sales and marketing strategies, will resonate strongly with consumers, positioning the brand for success in Germany's burgeoning market.